NEWTOWN, Pa., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback